The explanation could be that with a longer duration of antiretroviral therapy (ART), there is a potential for an increase in CD4 count, improved viral suppression, and a reduced likelihood of co-infection compared to the early stages of ART initiation. The gene discussed is CD4; the disease is coinfection.